Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Deferred Taxes: 2020-2023

Historic Deferred Taxes for Prime Medicine (PRME) over the last 4 years, with Dec 2023 value amounting to -$279,000.

  • Prime Medicine's Deferred Taxes fell 532.26% to -$134,000 in Q2 2024 from the same period last year, while for Jun 2024 it was -$77,000, marking a year-over-year increase of 52.17%. This contributed to the annual value of -$279,000 for FY2023, which is 71.06% up from last year.
  • According to the latest figures from FY2023, Prime Medicine's Deferred Taxes is -$279,000, which was up 71.06% from -$964,000 recorded in FY2022.
  • Over the past 5 years, Prime Medicine's Deferred Taxes peaked at $1.9 million during FY2020, and registered a low of -$964,000 during FY2022.
  • Moreover, its 3-year median value for Deferred Taxes was -$624,000 (2021), whereas its average is -$622,333.
  • As far as peak fluctuations go, Prime Medicine's Deferred Taxes slumped by 133.42% in 2021, and later skyrocketed by 71.06% in 2023.
  • Yearly analysis of 4 years shows Prime Medicine's Deferred Taxes stood at $1.9 million in 2020, then slumped by 133.42% to -$624,000 in 2021, then slumped by 54.49% to -$964,000 in 2022, then surged by 71.06% to -$279,000 in 2023.